Infant mortality rises after implementing abortion bans, study finds
In a recent study, the rate of infant deaths was increased by 5.6% in US states implementing abortion bans.
Study: Higher-dose atropine more effective in slowing myopia progression in children
0.05% atropine was associated with a higher incidence of mild side effects, though it was more effective in controlling myopia progression compared to 0.01% atropine or placebo.
Quiz: Recommendations for critical congenital heart disease newborn screenings
In this quiz, we test your knowledge of the AAP's new algorithm and updated recommendations for newborn screening for critical congenital heart disease.
Positive initial data reported for SGT-003 to treat Duchenne muscular dystrophy
90-day interim biopsy data in the first 3 patients revealed an average microdystrophin expression of 110% and improvements in muscle health and resilience biomarkers.
Reacting to the meningococcal ABCWY vaccine approval with Donna Hallas, PhD, PPCNP-BC
Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN offers her thoughts on the recent FDA approval of GSK's meningococcal ABCWY vaccine.
Weekly review: Several key FDA approvals, new puzzler case, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
FDA approves GSK's meningococcal ABCWY vaccine
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally.
FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment
The federal agency has approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.
Michael Kruer, MD explains genetic testing and cerebral palsy
Genetic research is revealing that up to 35% of cerebral palsy cases have an identifiable genetic cause, leading to earlier diagnoses and potential precision medicine treatments.
More screen time linked to higher stress, depressive symptoms in adolescence
Higher physical activity and lower screen time in childhood were linked to reduced stress and depression in adolescence, according to a Finnish cohort study.
Mental health treatment challenges in primary care
Peter S. Jensen, MD, comments on the challenges primary health care providers may face when it comes to mental health treatment in pediatrics, and provides screening tools to consider to combat these challenges.
EN-374 granted rare pediatric disease, orphan drug designations for chronic granulomatous disease
Ensoma's lead program, EN-374, has been granted a pair of FDA designations for the treatment of X-linked chronic granulomatous disease.
FDA approves non-invasive risdiplam tablet for spinal muscular atrophy
The new risdiplam tablet is suitable for those aged 2 years and older who weigh more than 44 lbs, according to Genentech.
A green nail after trauma in an 8-year-old boy
His mother reported that the nail had developed a green discoloration and had begun to detach approximately 1 week prior to the visit.
FDA approves mirdametinib for patients 2 years, older with neurofibromatosis type 1
Efficacy for the kinase inhibitor was based on the ReNue (NCT03962543 ) trial that featured 58 adults and 56 pediatric patients.
Direct oral anticoagulants for venous thromboembolism in pediatrics
A review of current guidelines in treatment and thromboprophylaxis.
Atypical presentations of Mycoplasma pneumoniae amid a local outbreak
M pneumoniae infection is not a reportable disease, and testing is often not performed in the outpatient setting, limiting estimates of clinical prevalence and delaying recognition of community epidemics.
Lidocaine gel eases the pain of removing an entrapped zipper
"Less pain and no need for sedation are major benefits," said Jon Matthew Farber, MD, in this edition of Journal Club.
Experts: Now is the time to be the biggest child health care advocate
In this discussion, leading experts weigh in on the importance of scientific integrity, proactive advocacy, and the crucial role of vaccinations in pediatric health.
Weekly review: New delgocitinib data for eczema, FDA action items, more
FDA accepts BLA for lerodalcibep for lowering LDL-cholesterol in patients with ASCVD
FDA grants rezpegaldesleukin fast track to treat moderate, severe atopic dermatitis
The investigational biologic targets the interleukin-2 receptor complex in the body in order to stimulate proliferation of inhibitory immune cells.
Educating your patients about the dangers of frostbite
Shriners Children’s Boston warns patients and their parents about frostbite risks, offering tips on prevention, signs, and treatment to keep kids safe in extreme cold.
Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1
Cyclo Therapeutics has enrolled 10 patients in a single-arm sub-study treating newborns to 3 years of age, evaluating the Trappsol Cyclo in the youngest subsets.
Debunking myths about diet and acne
A look into nutrition's role in acne care, highlighted by Colleen Sloan, PA-C, RDN.
Research finds non-allergic rhinoconjunctivitis phenotypes in children with asthma
Allergic sensitization was more prominent in severe phenotypes but did not explain seasonal differences.
Diabetes device data may fail to deliver based on smartphone settings
The FDA is warning diabetes patients that information from CGMs, insulin pumps, and automated dosing systems could fail to be delivered if smartphone settings are not properly configured.
FDA grants ABO-101 orphan, rare pediatric designations to treat primary hyperoxaluria type 1
The designations follow the FDA acceptance of IND application for ABO-101 to treat PH1, with a phase 1/2 study planned in the first half of 2025.
FDA news in pediatrics: January 2025
A recap of the FDA submissions and regulatory decisions in pediatrics from January 2025.
IV acetaminophen with opioids in EA/TEF repair has advantages and disadvantages
"I’m all for reducing opioids, especially in neonates, for whom we are unsure of long-term adverse effects," stated Jon Matthew Farber, MD.
